NexgenRx Inc. (TSXV:NXG)
Canada flag Canada · Delayed Price · Currency is CAD
0.360
0.00 (0.00%)
At close: Apr 27, 2026

NexgenRx Revenue

In the year 2025, NexgenRx had annual revenue of 17.93M CAD with 8.84% growth. NexgenRx had revenue of 4.42M in the quarter ending December 31, 2025, with 5.21% growth.

Revenue
17.93M
Revenue Growth
+8.84%
P/S Ratio
1.43
Revenue / Employee
896.62K
Employees
20
Market Cap
25.60M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202517.93M1.46M8.84%
Dec 31, 202416.48M2.63M18.99%
Dec 31, 202313.85M1.07M8.33%
Dec 31, 202212.78M939.94K7.94%
Dec 31, 202111.84M1.27M12.01%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Principal Technologies 370.42K
DIAGNOS 68.16K
Comprehensive Healthcare Systems 5.79M
AI/ML Innovations 125.47K
NetraMark Holdings 165.26K
Seegnal 1.72M
nDatalyze 887.00
Revenue Rankings